IBDEI1B7 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23495,1,5,0)
 ;;=5^Nodules, rheumatoid arthritis
 ;;^UTILITY(U,$J,358.3,23495,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,23496,0)
 ;;=733.82^^139^1445^11
 ;;^UTILITY(U,$J,358.3,23496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23496,1,3,0)
 ;;=3^733.82
 ;;^UTILITY(U,$J,358.3,23496,1,5,0)
 ;;=5^Nonunion of fracture
 ;;^UTILITY(U,$J,358.3,23496,2)
 ;;=^83875
 ;;^UTILITY(U,$J,358.3,23497,0)
 ;;=173.70^^139^1445^1
 ;;^UTILITY(U,$J,358.3,23497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23497,1,3,0)
 ;;=3^173.70
 ;;^UTILITY(U,$J,358.3,23497,1,5,0)
 ;;=5^Neoplasm, Skin Lower Limb
 ;;^UTILITY(U,$J,358.3,23497,2)
 ;;=^340603
 ;;^UTILITY(U,$J,358.3,23498,0)
 ;;=356.8^^139^1445^6
 ;;^UTILITY(U,$J,358.3,23498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23498,1,3,0)
 ;;=3^356.8
 ;;^UTILITY(U,$J,358.3,23498,1,5,0)
 ;;=5^Neuropathy, Idiopathic Perip,Oth Spec
 ;;^UTILITY(U,$J,358.3,23498,2)
 ;;=^268525
 ;;^UTILITY(U,$J,358.3,23499,0)
 ;;=703.8^^139^1445^10
 ;;^UTILITY(U,$J,358.3,23499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23499,1,3,0)
 ;;=3^703.8
 ;;^UTILITY(U,$J,358.3,23499,1,5,0)
 ;;=5^Nondystrophic Nails
 ;;^UTILITY(U,$J,358.3,23499,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,23500,0)
 ;;=703.0^^139^1446^1
 ;;^UTILITY(U,$J,358.3,23500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23500,1,3,0)
 ;;=3^703.0
 ;;^UTILITY(U,$J,358.3,23500,1,5,0)
 ;;=5^Onychocryptosis (Ingrown toe nail)
 ;;^UTILITY(U,$J,358.3,23500,2)
 ;;=^81221
 ;;^UTILITY(U,$J,358.3,23501,0)
 ;;=757.5^^139^1446^2
 ;;^UTILITY(U,$J,358.3,23501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23501,1,3,0)
 ;;=3^757.5
 ;;^UTILITY(U,$J,358.3,23501,1,5,0)
 ;;=5^Onchodystrophy/Onycholysis; Congenital
 ;;^UTILITY(U,$J,358.3,23501,2)
 ;;=^273090
 ;;^UTILITY(U,$J,358.3,23502,0)
 ;;=703.8^^139^1446^3
 ;;^UTILITY(U,$J,358.3,23502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23502,1,3,0)
 ;;=3^703.8
 ;;^UTILITY(U,$J,358.3,23502,1,5,0)
 ;;=5^Onchodystrophy/Onycholysis; Acquired
 ;;^UTILITY(U,$J,358.3,23502,2)
 ;;=^271926
 ;;^UTILITY(U,$J,358.3,23503,0)
 ;;=110.1^^139^1446^4
 ;;^UTILITY(U,$J,358.3,23503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23503,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,23503,1,5,0)
 ;;=5^Onychomycosis
 ;;^UTILITY(U,$J,358.3,23503,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,23504,0)
 ;;=715.37^^139^1446^6
 ;;^UTILITY(U,$J,358.3,23504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23504,1,3,0)
 ;;=3^715.37
 ;;^UTILITY(U,$J,358.3,23504,1,5,0)
 ;;=5^Osteoarthrosis, localized, not specified whether primary or secondary; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,23504,2)
 ;;=^272156
 ;;^UTILITY(U,$J,358.3,23505,0)
 ;;=715.90^^139^1446^7
 ;;^UTILITY(U,$J,358.3,23505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23505,1,3,0)
 ;;=3^715.90
 ;;^UTILITY(U,$J,358.3,23505,1,5,0)
 ;;=5^Osteoarthrosis, unspecified whether generalized or localized
 ;;^UTILITY(U,$J,358.3,23505,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,23506,0)
 ;;=730.07^^139^1446^8
 ;;^UTILITY(U,$J,358.3,23506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23506,1,3,0)
 ;;=3^730.07
 ;;^UTILITY(U,$J,358.3,23506,1,5,0)
 ;;=5^Osteomyelitis, Acute; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,23506,2)
 ;;=^272619
 ;;^UTILITY(U,$J,358.3,23507,0)
 ;;=730.17^^139^1446^9
 ;;^UTILITY(U,$J,358.3,23507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23507,1,3,0)
 ;;=3^730.17
 ;;^UTILITY(U,$J,358.3,23507,1,5,0)
 ;;=5^Osteomyelitis, Chronic; ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,23507,2)
 ;;=^272628
 ;;^UTILITY(U,$J,358.3,23508,0)
 ;;=730.27^^139^1446^10
 ;;^UTILITY(U,$J,358.3,23508,1,0)
 ;;=^358.31IA^5^2
